MIDAZOLAM INJECTION
MIDAZOLAM INJECTION
Approved
DIN Number
02240285
Drug Class
Human
Market Date
Jul 21, 1999
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02240285
AIG Number0119935002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD08 MIDAZOLAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MIDAZOLAMActive
Strength: 1 MG / ML
Monograph: MIDAZOLAM